Abstract
Heat shock proteins are well-known protectors from cell death. Cell death (in particular, apoptosis and necrosis) is accompanied by certain hallmarks manifested as specific alterations in cellular membranes, cytoplasm, nucleus, and mitochondria. Some of those hallmarks are easily detectable in situ and, therefore, they can be applied for the assessment of dying or dead cells. In turn, there are also signs of viable cells that include such features as normal functioning of their membranes and organelles, ability to proliferate, etc. This chapter describes several convenient methods for quantification of dead (apoptotic and necrotic) cells as well as methods for assessment of viable cells. We describe in detail methods of annexin V/propidium iodide (PI) staining, TUNEL assay, Hoechst/PI staining, caspase activation, MTS tetrazolium, lactate dehydrogenase (LDH) release, colony formation, and senescence assays, with the principles, advantages, and drawbacks of each technique.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Garrido C, Schmitt E, Cande C, Vahsen N, Parcellier A, Kroemer G (2003) HSP27 and HSP70: potentially oncogenic apoptosis inhibitors. Cell Cycle 2(6):579–584
Beere HM (2005) Death versus survival: functional interaction between the apoptotic and stress-inducible heat shock protein pathways. J Clin Invest 115(10):2633–2639
Yamashima T (2012) Hsp70.1 and related lysosomal factors for necrotic neuronal death. J Neurochem 120(4):477–494. https://doi.org/10.1111/j.1471-4159.2011.07596.x
Calderwood SK, Khaleque MA, Sawyer DB, Ciocca DR (2006) Heat shock proteins in cancer: chaperones of tumorigenesis. Trends Biochem Sci 31(3):164–172
O’Callaghan-Sunol C, Gabai VL (2007) Involvement of heat shock proteins in protection of tumor cells from genotoxic stresses. In: Calderwood S, Sherman MY, Ciocca DR (eds) Heat shock proteins in cancer, 1st edn. Springer, New York, pp 169–190
Galluzzi L, Vitale I, Abrams JM, Alnemri ES, Baehrecke EH, Blagosklonny MV, Dawson TM, Dawson VL, El-Deiry WS, Fulda S, Gottlieb E, Green DR, Hengartner MO, Kepp O, Knight RA, Kumar S, Lipton SA, Lu X, Madeo F, Malorni W, Mehlen P, Nunez G, Peter ME, Piacentini M, Rubinsztein DC, Shi Y, Simon HU, Vandenabeele P, White E, Yuan J, Zhivotovsky B, Melino G, Kroemer G (2012) Molecular definitions of cell death subroutines: recommendations of the Nomenclature Committee on Cell Death 2012. Cell Death Differ 19(1):107–120
Raynal P, Pollard HB (1994) Annexins: the problem of assessing the biological role for a gene family of multifunctional calcium- and phospholipid-binding proteins. Biochim Biophys Acta 1197(1):63–93. https://doi.org/10.1016/0304-4157(94)90019-1
Martin SJ, Reutelingsperger CP, McGahon AJ, Rader JA, van Schie RC, LaFace DM, Green DR (1995) Early redistribution of plasma membrane phosphatidylserine is a general feature of apoptosis regardless of the initiating stimulus: inhibition by overexpression of Bcl-2 and Abl. J Exp Med 182(5):1545–1556. https://doi.org/10.1084/jem.182.5.1545
Vermes I, Haanen C, Steffens-Nakken H, Reutellingsperger C (1995) A novel assay for apoptosis flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled Annexin V. J Immunol Methods 184(1):39–51. https://doi.org/10.1016/0022-1759(95)00072-I
Casciola-Rosen L, Rosen A, Petri M, Schlissel M (1996) Surface blebs on apoptotic cells are sites of enhanced procoagulant activity: implications for coagulation events and antigenic spread in systemic lupus erythematosus. Proc Natl Acad Sci U S A 93(4):1624–1629
van Engeland M, Ramaekers FCS, Schutte B, Reutelingsperger CPM (1996) A novel assay to measure loss of plasma membrane asymmetry during apoptosis of adherent cells in culture. Cytometry 24(2):131–139. https://doi.org/10.1002/(sici)1097-0320(19960601)24:2<131::aid-cyto5>3.0.co;2-m
Samejima K, Earnshaw WC (2005) Trashing the genome: the role of nucleases during apoptosis. Nat Rev Mol Cell Biol 6(9):677–688
Gavrieli Y, Sherman Y, Ben-Sasson SA (1992) Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol 119(3):493–501. https://doi.org/10.1083/jcb.119.3.493
Lauber K, Blumenthal SG, Waibel M, Wesselborg S (2004) Clearance of apoptotic cells. Mol Cell 14(3):277–287. https://doi.org/10.1016/s1097-2765(04)00237-0
Thornberry NA, Lazebnik Y (1998) Caspases: enemies within. Science 281(5381):1312–1316. https://doi.org/10.1126/science.281.5381.1312
Nicholson DW, Ali A, Thornberry NA, Vaillancourt JP, Ding CK, Gallant M, Gareau Y, Griffin PR, Labelle M, Lazebnik YA, Munday NA, Raju SM, Smulson ME, Yamin T-T, Yu VL, Miller DK (1995) Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis. Nature 376(6535):37–43
Fernandes-Alnemri T, Litwack G, Alnemri ES (1994) CPP32, a novel human apoptotic protein with homology to Caenorhabditis elegans cell death protein Ced-3 and mammalian interleukin-1 beta-converting enzyme. J Biol Chem 269(49):30761–30764
Roninson IB (2003) Tumor cell senescence in cancer treatment. Cancer Res 63(11):2705–2715
Yaglom JA, Gabai VL, Sherman MY (2007) High levels of heat shock protein Hsp72 in cancer cells suppress default senescence pathways. Cancer Res 67(5):2373–2381. https://doi.org/10.1158/0008-5472.CAN-06-3796
Meng L, Hunt C, Yaglom JA, Gabai VL, Sherman MY (2011) Heat shock protein Hsp72 plays an essential role in Her2-induced mammary tumorigenesis. Oncogene 30(25):2836–2845
Dimri G, Lee X, Basile G, Acosta M, Scott G, Roskelley C, Medrano E, Linskens M, Rubelj I, Pereira-Smith O, Peacocke M, Campisi J (1995) A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc Natl Acad Sci U S A 92(20):9363–9367
Roninson IB (2002) Tumor senescence as a determinant of drug response in vivo. Drug Resist Updates 5(5):204–208
Roninson IB, Broude EV, Chang B-D (2001) If not apoptosis, then what? Treatment-induced senescence and mitotic catastrophe in tumor cells. Drug Resist Updates 4(5):303–313
Schmitt CA (2007) Cellular senescence and cancer treatment. Biochim Biophys Acta 1775(1):5–20
Rossi A, Ciafrè S, Balsamo M, Pierimarchi P, Santoro MG (2006) Targeting the heat shock factor 1 by RNA interference: a potent tool to enhance hyperthermochemotherapy efficacy in cervical cancer. Cancer Res 66(15):7678–7685. https://doi.org/10.1158/0008-5472.can-05-4282
Kabakov AE, Kudryavtsev VA, Gabai VL (2010) Hsp90 inhibitors as promising agents for radiotherapy. J Mol Med (Berl) 88(3):241–247. https://doi.org/10.1007/s00109-009-0562-0
Westerheide SD, Kawahara TLA, Orton K, Morimoto RI (2006) Triptolide, an inhibitor of the human heat shock response that enhances stress-induced cell death. J Biol Chem 281(14):9616–9622. https://doi.org/10.1074/jbc.M512044200
Author information
Authors and Affiliations
Corresponding authors
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer Science+Business Media, LLC
About this protocol
Cite this protocol
Kabakov, A.E., Gabai, V.L. (2018). Cell Death and Survival Assays. In: Calderwood, S., Prince, T. (eds) Chaperones. Methods in Molecular Biology, vol 1709. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-7477-1_9
Download citation
DOI: https://doi.org/10.1007/978-1-4939-7477-1_9
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-7476-4
Online ISBN: 978-1-4939-7477-1
eBook Packages: Springer Protocols